Cost-effectiveness of a digital supportive healthcare pathway for type 2 diabetes compared to usual care in Belgium.

ABSTRACT:

Objective

To evaluate the cost-effectiveness of a digital supportive healthcare pathway in patients with type 2 diabetes mellitus (T2DM) compared to usual care.

Methods

An age-dependent Markov model was applied from a healthcare payer perspective projecting results of a clinical trial study over a time horizon of 22 years assuming a continuous implementation of the intervention every year, 24/7. The setting was Flanders (Belgium). One-way and probabilistic sensitivity analyses were performed.

Results

The hybrid care pathway led to a quality-adjusted life year (QALY) gain of 5.97, while the costs increased with €663,036. This resulted in an incremental cost-effectiveness ratio of €110,989/QALY. With a cost-effectiveness threshold of 45,000€/QALY, the hybrid care pathwa

SUBMITTER: Van Wilder L 

PROVIDER: S-EPMC11866382 | biostudies-literature | 2025 Jan-Dec

REPOSITORIES: biostudies-literature